arginine and Agranulocytosis

arginine has been researched along with Agranulocytosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Pauw, BE; Du Bois, W; Verhagen, C; Williams, KJ1
Carreras, E; Grañena, A; Marín, P; Olivé, MT; Rozman, C; Sierra, J1
Babare, R; Carbone, A; Lazzarini, R; Merola, MC; Monfardini, S; Talamini, R; Tirelli, U; Zagonel, V1

Trials

1 trial(s) available for arginine and Agranulocytosis

ArticleYear
Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Arginine; Bacterial Infections; Carbonates; Ceftazidime; Clinical Trials as Topic; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Prospective Studies; Random Allocation

1988

Other Studies

2 other study(ies) available for arginine and Agranulocytosis

ArticleYear
[VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
    Sangre, 1984, Volume: 29, Issue:4-A

    Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Drug Evaluation; Female; Humans; Leukemia, Lymphoid; Male; Podophyllotoxin; Teniposide

1984
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Age Factors; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Infection Control; Length of Stay; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Safety; Teniposide; Treatment Outcome; Vincristine

1994